- The EMA at 20: CHMP chair on HTA, patient involvement and dealing with uncertainty
- STOCKWATCH: EU conditional approvals – what gives?
- CHMP nod for Chiesi's Holoclar, Europe's first stem cell therapy
- German HTA slams cagey Chiesi disclosure on Glybera bad news
ANALYSIS Other Informa Analysis
- INTERVIEW: Biogen's Danos on why now is gene therapy's time
- The EMA at 20: CAT chair on where all the advanced therapies are, and Holoclar, the bright light of stem cell therapy
JOB OF THE WEEK Promote your job vacancy